Literature DB >> 10794428

Correlation of loss of CD4 T cells with plasma levels of both soluble form Fas (CD95) Fas ligand (FasL) in HIV-infected infants.

N Hosaka1, N Oyaizu, S Than, S Pahwa.   

Abstract

Fas and Fas ligand (FasL), members of the TNFR and TNF families of molecules involved in apoptosis, respectively, are expressed in membrane-associated as well as soluble forms. Soluble Fas (sFas) and sFasL were evaluated in sequential samples from 16 HIV-infected and 11 HIV-exposed uninfected infants at ages 0-13 months. Regardless of the state of infection, age-dependent decreases in peripheral CD4 T cell counts and increases in sFas and sFasL were noted. However, decreases of the percentage CD4 T cells were more prominent in HIV-infected infants, and this was correlated significantly with increased plasma levels of sFas and sFasL (P = 0.002 and 0.004, respectively). Moreover, the levels of sFas in HIV-infected infants were found to be directly correlated with plasma HIV RNA (P = 0.03) and were significantly increased as early as age <1 month and prior to the onset of CD4 T cell decline. In uninfected infants, there was no such correlation between CD4 counts and the levels of sFas/sFasL. Plasma levels of sFas and sFasL may thus be important indicators of disease progression in perinatal HIV infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10794428     DOI: 10.1006/clim.2000.4843

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  2 in total

1.  Soluble Fas and Fas ligand in HIV/HCV coinfected patients and impact of HCV therapy.

Authors:  M Guzmán-Fulgencio; J Berenguer; M García-Álvarez; D Micheloud; J C López; J Cosín; I Fernández de Castro; P Catalán; P Miralles; S Resino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-03-26       Impact factor: 3.267

2.  Epigenetic Mechanisms Underlying HIV-Infection Induced Susceptibility of CD4+ T Cells to Enhanced Activation-Induced FasL Expression and Cell Death.

Authors:  Smita S Ghare; Paula M Chilton; Aakarsha V Rao; Swati Joshi-Barve; Paula Peyrani; Andrea Reyes Vega; Craig J McClain; Kendall Bryant; Robert L Cook; Mathew Freiberg; Shirish Barve
Journal:  J Acquir Immune Defic Syndr       Date:  2021-01-01       Impact factor: 3.771

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.